Insomnia
Not recruitingStudy on the Effects of Tasipimidine for Patients with Insomnia Disorder
- Disease:Insomnia
- Substances:Tasipimidine
Poland- Participants:18–64 years · 65+ years
- Substances:Tasipimidine
- Sponsor:Orion Corporation
Rare diseases
Investigational molecules
Locations
Ul. Czechoslowacka 8/10, 92-216 Lodz, Poland
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego W Lodzi in Lodz, Poland specialises in clinical trials of conditions such as Insomnia, Cognitive disorder, Schizophrenia, Chronic kidney disease-associated pruritus, and other specialisations. This site conducts important research.
At this research site in Lodz, clinical trials in Nervous System Diseases focus on improving care for people with insomnia disorder and related sleep problems. The studies are designed to assess whether new therapies can help restore healthier sleep patterns and reduce the burden of persistent insomnia.
This work supports better understanding of sleep-related conditions and the search for more effective treatment options at Samodzielny Publiczny Zaklad Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego W Lodzi.
The Klinika Zaburzeń Afektywnych i Psychotycznych is also involved in trials within Psychiatry and Psychology, with a strong emphasis on schizophrenia and associated cognitive disorder. These studies aim to understand whether new therapies can improve cognitive performance and support better overall outcomes for people living with serious mental illness.
The research reflects a broader effort to improve both symptom management and everyday functioning in psychiatric care.
Clinical trials registered at this site – none is enrolling right now.
Poland
Poland
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.